Stem cell therapies have the potential to treat a vast range of conditions, from forms of blindness to Parkinson’s disease, but manufacturing these products is difficult. The UK medtech regulator is exploring whether a robot could solve this problem.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has teamed up with Scottish regenerative medicine start-up SAKARTA and Tokyo-based electrical equipment manufacturer Sinfonia Technology to trial the use of the CellQualia Intelligent Cell Processing System, the regulator announced in a recent statement.
The MHRA is trialing one of just two CellQualia cell processing robots in use across the globe. The other system is in Japan, where the machine concept was developed.
German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.
Announced after three years of negotiation, the FTA eliminates tariffs on 99% of Indian product types, covering nearly all trade value, and reduces tariffs on 90% of UK products. Although not yet formally signed, the deal is being positioned by the Indian government as “transformative,” with an estimated economic impact of $6.4bn for the UK alone by 2040.
Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.
